4-苯基哌嗪-1-甲酰胺 | 77464-11-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 中文名称: 4-苯基哌嗪-1-甲酰胺
• 英文名称: 4-phenyl-1-piperazinecarboxamide
• 英文别名: 4-phenylpiperazine-1-carboxamide
• CAS: 77464-11-0
• 化学式: C₁₁H₁₅N₃O
• mdl: MFCD00214814
• 分子量: 205.26
• InChiKey: YIXRJXPKZRHXKM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  15
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.363
• 拓扑面积：
  49.6
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-苯基哌嗪-1-甲酰胺 在 sodium hydroxide 、 三乙胺 作用下， 以 氯仿 为溶剂， 以50%的产率得到4-苯基-1-哌嗪甲腈
  参考文献：
  名称：

  Schroth, W.; Kluge, H.; Frach, R., Journal fur praktische Chemie (Leipzig 1954), 1983, vol. 325, # 5, p. 787 - 802

  摘要：

  DOI：
• 作为产物：
  描述：

  N-苯基哌嗪 、 硝基脲 以 水 为溶剂， 反应 0.5h， 以55%的产率得到4-苯基哌嗪-1-甲酰胺
  参考文献：
  名称：

  Schroth, W.; Kluge, H.; Frach, R., Journal fur praktische Chemie (Leipzig 1954), 1983, vol. 325, # 5, p. 787 - 802

  摘要：

  DOI：

文献信息

• Allophanoylpiperazine compound and analgesic composition containing same
  申请人：Taiho Pharmaceutical Company Limited

  公开号：US04666911A1

  公开（公告）日：1987-05-19

  An analgesic compositon containing as active ingredient an allophanoylpiperazine compound represented by the general formula ##STR1## wherein R.sup.1 represents a lower alkyl group or phenyl group; R.sup.2 and R.sup.3 each represents a hydrogen atom or a lower alkyl group; and R.sup.4 represents a phenyl group or a substituted phenyl group having as substituent a halogen atom or methyl, trifluoromethyl, hydroxyl, methoxy, methylenedioxy, nitro, or carboxyl group; pyridyl group, pyrimidyl group, thiazolyl group, benzyl group, cinnamyl group, cyclohexyl group, a lower alkyl group, a substituted lower alkyl group having chlorine atom or hydroxyl group as substituent; or a lower alkenyl group.

  一种镇痛组合物，其活性成分为由通式##STR1##所表示的异脲酰哌嗪化合物，其中R.sup.1代表较低的烷基或苯基；R.sup.2和R.sup.3各自代表氢原子或较低的烷基；R.sup.4代表苯基或取代苯基，其取代基为卤原子或甲基、三氟甲基、羟基、甲氧基、亚甲二氧基、硝基或羧基；吡啶基、嘧啶基、噻唑基、苄基、肉桂基、环己基、较低的烷基、取代的较低的烷基，其取代基为氯原子或羟基；或较低的烯基。
• [EN] 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES<br/>[FR] DERIVES AMIDES DE L'ACIDE CARBOXYLIQUE DE 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE 3 ET COMPOSES ASSOCIES EN TANT QU'ANTAGONISTES DE RECEPTEUR DE B1 DE LA BRADYKININE POUR LE TRAITEMENT DE MALADIES INFLAMMATOIRES
  申请人：ELAN PHARM INC

  公开号：WO2004098589A1

  公开（公告）日：2004-11-18

  Disclosed are compounds of formula I and II that are bradykinin B1 receptor antagonists and are useful for treating diseases, or relieving adverse symptoms associated with disease conditions, in mammals mediated by bradykinin B1 receptor. Certain of the compounds exhibit increased potency and are also expected to exhibit increased duration of action.

  公开的是化合物I和II的结构式，它们是激肽酶B1受体拮抗剂，适用于治疗哺乳动物中由激肽酶B1受体介导的疾病，或缓解与疾病状况相关的不良症状。其中某些化合物表现出增强的效力，并且预计还将表现出延长作用的特性。
• [EN] TRUNCATED ITRACONAZOLE ANALOGUES AND METHODS OF USE THEREOF<br/>[FR] ANALOGUES D'ITRACONAZOLE TRONQUÉS ET LEURS PROCÉDÉS D'UTILISATION
  申请人：UNIV CONNECTICUT

  公开号：WO2021030174A1

  公开（公告）日：2021-02-18

  Disclosed herein are analogues of itraconazole that are potent hedgehog signaling pathway inhibitors. The compounds are expected to be useful in the treatment of cell proliferation disorders such as cancer, particularly cancers that are dependent upon the hedgehog signaling pathway such as basal cell carcinoma and medulloblastoma.

  本文披露了伊曲康唑的类似物，它们是有效的刺刺信号通路抑制剂。这些化合物预计在治疗细胞增殖紊乱疾病如癌症方面将会很有用，特别是那些依赖于刺刺信号通路的癌症，如基底细胞癌和髓母细胞瘤。
• Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists
  申请人：Tung S. Jay

  公开号：US20050020659A1

  公开（公告）日：2005-01-27

  Disclosed are compounds that are bradykinin B 1 receptor antagonists and are useful for treating diseases, or relieving adverse symptoms associated with disease conditions, in mammals mediated by bradykinin B 1 receptor. Certain of the compounds exhibit increased potency and are also expected to exhibit increased duration of action.

  本发明公开了一种布雷肯肽B1受体拮抗剂化合物，可用于治疗哺乳动物中由布雷肯肽B1受体介导的疾病或缓解与疾病状况相关的不良症状。其中某些化合物表现出增强的效力，并且预计也会表现出增强的作用持续时间。
• 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carvoxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
  申请人：Tung S. Jay

  公开号：US20060281733A1

  公开（公告）日：2006-12-14

  Disclosed are compounds of formula I and II that are bradykinin B 1 receptor antagonists and are useful for treating diseases, or relieving adverse symptoms associated with disease conditions, in mammals mediated by bradykinin B 1 receptor. Certain of the compounds exhibit increased potency and are also expected to exhibit increased duration of action.

  本发明公开了式I和式II的化合物，它们是缓激肽B1受体拮抗剂，可用于治疗哺乳动物中由缓激肽B1受体介导的疾病，或缓解与疾病条件相关的不良症状。其中某些化合物表现出增强的效力，预计也会表现出增强的持续时间。